IQVIA alternatives for mid-market sponsors who want technology, not a services contract
If you want the technology without signing a full-service CRO contract, IQVIA's model isn't really built for that. WeGuide is a standalone patient engagement platform: eCOA, eConsent, wearables, whitelabel apps, TGA certified and ISO 27001, with your team running the study instead of an outsourced service line.
No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.
.png)
Used by leading research and medical institutes.
%201.avif)
Why research teams look for an IQVIA alternative
The conversation usually starts with technology and ends with services. A sponsor walks into an IQVIA engagement looking for eCOA, patient engagement, registries, or real-world evidence, and discovers the technology is priced and delivered alongside a professional services wrap. The CRO work is charged by the hour, the technology sits inside the contract, and the whole thing is configured by IQVIA staff rather than by the sponsor's own research team.
For enterprise pharma running a full service multi country Phase III trial, that's exactly what they want. One partner, one contract, one delivery team. For mid market biotech, emerging sponsors, academic CROs, or sponsors with their own clinical operations capability, it's the opposite of what they want. They already have the team. They don't need to buy services. They just want the platform.
The other recurring issue is configurability. IQVIA Technologies is built around the assumption that IQVIA staff will configure and run the platform. Self-service tooling, no-code configuration, and day-to-day administrative control by the sponsor's research team aren't the delivery model. For sponsors who want to own and operate the platform themselves, that constraint becomes the deal-breaker.
WeGuide is built the other way around. We're a patient engagement and clinical trial platform sold as pure technology, configured by the sponsor's own team through a no-code programme builder, with no service contract wrap. If you want a CRO services relationship, IQVIA is a better choice. If you want the platform, keep reading.
.png)
Key differences between WeGuide and IQVIA
For teams that want the platform without the services wrap, here's what changes when you move from IQVIA Technologies to WeGuide.
.png)
Whitelabel participant mobile apps
.png)
Native wearable integration
.png)
No code configuration by research teams
Full comparison: WeGuide vs IQVIA
.png)
Top alternatives to IQVIA in 2026
Here's the shortlist of platforms most teams evaluate when they need clinical trial technology without an IQVIA services contract.
.png){kind=small}
All-in-one platform
WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.
.png){kind=icon}
eConsent
.png)
.png){kind=icon}
Screening
.svg)
.svg)
.png){kind=icon}
Data collection
.svg)
.png){kind=icon}
Telehealth
.png)
.png)
.png)
%20(1)%20(1)%20(1).png)
%20(1).png)
.png)
.png)
Continuous engagement, not once-off surveys
Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →
Push notifications and reminders
Study companion
Educational content and gamification
Mobile multimodal collection
Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.
Forms
.svg){kind=icon}
Video
.svg){kind=icon}
Pathology
.svg){kind=icon}
Sensors
.png)
%20(1).png)
.png)
%20(1).png)
.png)
%20(1).png)
.png)
Whitelabel: your study, your brand
WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.
.svg){kind=icon}
Your brand end-to-end
.svg){kind=icon}
App store distribution
.svg){kind=icon}
Multilingual out of the box.
Where WeGuide goes further
For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.
.svg)
Technology first, not services first
No code configuration by research teams
Accessible pricing for mid market research
.svg)
Whitelabel participant apps under your brand
.svg)
Native wearable integration
.png)
Self serve patient registry platform
Employee wellbeing, population health, and general healthcare use cases
Deploy in weeks, not months
Built for regulated research
Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.
.png){kind=small}
TGA Certified
.png){kind=small}
ISO 27001
.png){kind=small}
Data Hosted in Australia
.png){kind=small}
GDPR Compliant
Biometric Security
.png){kind=small}
256-bit AES Encryption
Faster
Your own platform ready in weeks and changes are made in minutes
Adherence Rates
High patient engagement and better quality data
Cost Saving
Reduce financial and technology risk when creating a secure health app
Patients Impacted
With our ease of use and roll out, our apps have engaged 200k+ users
Where IQVIA excels
Full service CRO delivery. IQVIA employs more than 30,000 people across clinical operations, site management, monitoring, medical writing, regulatory affairs, biostatistics, and data management. For sponsors who want a single partner to run a trial end to end, there's very little IQVIA can't cover. That's a genuine strength and not something WeGuide offers.
Topical authority across the clinical trial stack. IQVIA's product pages rank #1 or in the top few for patient engagement software, patient registry software, real-world evidence solutions, and clinical data management software. That SEO footprint reflects a substantial content investment and a broad product portfolio.
Real world evidence and proprietary data assets. IQVIA has decades of investment in claims data, EMR data, and other real-world evidence sources that most technology vendors don't touch. For sponsors who need RWE consulting backed by proprietary datasets, IQVIA's position is hard to replicate.
Global reach and therapeutic area depth. IQVIA has run studies across essentially every therapeutic area in essentially every country where trials are possible. For globally distributed Phase III programmes, that operational footprint matters.
Integrated services plus technology relationship. For the sponsors who want everything from one partner, IQVIA is the largest of the full-service CRO plus technology offerings. The relationship is genuinely integrated.
If your sponsor needs a CRO services relationship, IQVIA is a legitimate choice and WeGuide does not replace it. We're a technology platform, not a CRO.
WeGuide works alongside IQVIA services
If your sponsor retains IQVIA for CRO services but wants to own the participant facing technology independently, the two relationships can coexist. WeGuide runs the patient engagement platform (eCOA, eConsent, wearables, registry, telehealth), while IQVIA handles site management, monitoring, and clinical operations under the services contract. Our Integration Engine connects into CRO data flows, and many of the teams we work with run hybrid setups like this.
How the switch works
For teams that are evaluating IQVIA Technologies but want a pure-platform alternative, or for sponsors who want to run WeGuide alongside an IQVIA services contract, here's how onboarding typically plays out.
Discovery Call
A 30-minute conversation with one of our research delivery team. We look at your protocol, your current CRO relationship, and what's actually blocking you. No sales pitch.
Study Configuration
Our team works alongside yours to configure the study in WeGuide. Typical timeline: two to four weeks. If you want your own research team to run configuration, we train them and step back.
.svg)
Participant Onboarding
The whitelabel app goes live under your organisation's brand. Research coordinators invite participants, and consent flows, eCOA instruments, and engagement templates are ready.
Ongoing Support
You get a named research delivery contact, not a billable professional services engagement. We stay involved for the life of the study at no incremental hourly rate.
.png)
.png)
.png)
.png)
Case studies: research teams that wanted the platform, not the services
BRACE Trial (Murdoch Children's Research Institute)
A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. Launched across five countries with 6,000+ participants in six weeks during the pandemic. MCRI ran the clinical operations themselves and used WeGuide as the platform, not a CRO.
GenV (Generation Victoria)
A population health study tracking more than 100,000 Victorian families from birth. GenV has its own operational team and needed a platform they could configure, own, and run without a services wrap. The whitelabel family-facing app is the reason retention has held across multiple years.
INHERIT
A specialist patient registry for facioscapulohumeral muscular dystrophy, run by the FSHD community itself rather than an outsourced services provider. Longitudinal participant reported outcomes, wearable integration, and multi-year participant relationships, all operated by the disease community's own team.
%201.avif)
Questions
Straight answers on how WeGuide compares to IQVIA, what the delivery model looks like, and when IQVIA is still the right choice.
Contact usIs WeGuide a full replacement for IQVIA?
Honestly, it depends on what you're buying from IQVIA. If you need CRO services (site management, monitoring, medical writing, regulatory affairs, biostatistics, and clinical operations staff), IQVIA is a service provider and WeGuide is not. We don't run trials, we provide the platform teams use to run them. If you need clinical trial technology only (eCOA, eConsent, patient engagement, registries, wearables, telehealth), WeGuide delivers that without a services contract, and for mid-market sponsors that's typically a much better fit.
Can WeGuide work alongside an IQVIA services engagement?
Yes. Many sponsors retain a CRO for services while using WeGuide for the participant facing technology. The two contracts can run in parallel. IQVIA manages site operations, monitoring, and clinical operations under the services contract, and WeGuide manages the platform layer directly with the sponsor. Our Integration Engine can connect into IQVIA data flows where needed.
How does IQVIA's patient registry compare to WeGuide's?
IQVIA's patient registry offering is primarily services led, with IQVIA data operations staff running day-to-day registry work. WeGuide's registry is a configurable self serve platform that the sponsor's own team operates. The FSHD Global Registry is a good proof point: a specialist disease registry running longitudinally, operated by the FSHD community's own team, not an outsourced services provider. Different delivery models for different customer profiles.
Does WeGuide have real world evidence tools like IQVIA?
Different kinds of RWE. WeGuide collects real world evidence from participants' own devices (Garmin, Apple Health, Google Fit), validated ePRO instruments, and eCOA assessments, all delivered through the participant facing app. That's participant-generated RWE. IQVIA's RWE business is built around proprietary claims and EMR datasets plus consulting, which is a completely different kind of real world evidence and one we don't replace. For sponsors who need IQVIA's claims and EMR data, IQVIA is the right choice. For sponsors who need participant generated RWE at scale, WeGuide is the right platform.
How do IQVIA and WeGuide compare on eCOA?
IQVIA ranks #4 in Google for "ecoa clinical trials" through a dedicated product page, reflecting IQVIA's investment in eCOA content and product. WeGuide's eCOA is integrated into the Form Builder with a library of 200+ validated instruments and runs inside the same whitelabel app participants use for the rest of the study. The core difference is that IQVIA's eCOA is typically delivered inside a services engagement, while WeGuide's eCOA is configured and run by the sponsor's own research team.
What's the typical deployment timeline?
IQVIA implementations typically take three months or longer because of the professional services configuration model. WeGuide deploys in weeks. The BRACE Trial launched across five countries with 6,000+ participants in six weeks during the COVID-19 pandemic, and that's our benchmark for a rapid-deploy multi-site study. Simpler studies can launch in two to three weeks.
Compare WeGuide to other clinical trial platforms
Eleven more honest platform comparisons, from academic EDC to enterprise pharma.
.png){kind=small}
Veeva Vault Clinical
Life sciences cloud
Thread Research
Virtual CRO + software
Clario
eCOA specialist
Oracle Clinical
Clinical One & InForm
.png){kind=small}
OpenClinica
Open-source EDC
.png){kind=small}
Medable
DCT for top-50 pharma
.png){kind=small}
IQVIA
Full-service CRO
Florence Healthcare
Site-side workflow
Science 37
Open-source EDC
obviohealth
Virtual site service
Medidata Rave
Enterprise pharma stack
REDCap
Data Collection
Never miss an update
Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.
By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.
Certified and Compliant by Leading Standards
